7435 Clinical Trials for: SEARCH[STUDY] DOC[LOCATION] “United States” [LOCATION:LOCATION-COUNTRY], “Indiana” [LOCATION:LOCATION-STATE], Page 2 of 372

Hide Studies Not Seeking New Volunteers

21

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Condition(s): Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; Male Breast Carcinoma; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer Last Updated: April 27, 2016Active, not recruiting